DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
JZP-110 is an investigational drug.
There have been 11 clinical trials for JZP-110. The most recent clinical trial was a Phase 1 trial, which was initiated on May 1st 2015.
The most common disease conditions in clinical trials are Narcolepsy, Disorders of Excessive Somnolence, and Sleep Apnea, Obstructive. The leading clinical trial sponsors are Jazz Pharmaceuticals, Children's Oncology Group (COG), and Concert Pharmaceuticals.
There are twenty-seven US patents protecting this investigational drug and one hundred and ninety-nine international patents.
Recent Clinical Trials for JZP-110
|An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)||Children's Oncology Group (COG)||Phase 2/Phase 3|
|An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)||Jazz Pharmaceuticals||Phase 2/Phase 3|
|A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension||Jazz Pharmaceuticals||Phase 3|
Top disease conditions for JZP-110
Top clinical trial sponsors for JZP-110
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|JZP-110||Start Trial||Formulations of (R)-2-amino-3-phenylpropyl carbamate||Jazz Pharmaceuticals International III Limited (Hamilton, BM)||Start Trial|
|JZP-110||Start Trial||Methods for treating attention-deficit/hyperactivity disorder||SK Biopharmaceuticals Co., Ltd. (Seongnam-si, Gyeonggi-do, KR)||Start Trial|
|JZP-110||Start Trial||Treatment of cataplexy||Jazz Pharmaceuticals International III Limited (Hamilton, BM) SK Biopharmaceuticals Co., Ltd. (Seoul, KR)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|